Nanobiotechnology advanced antifouling surfaces for the continuous electrochemical monitoring of glucose in whole blood using a lab-on-a-chip
- 19 February 2013
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 13 (9) , 1780-1789
Abstract
In the current work we have developed a lab-on-a-chip containing embedded amperometric sensors in four microreactors that can be addressed individually and that are coated with crystalline surface protein monolayers to provide a continuous, stable, reliable and accurate detection of blood glucose. It is envisioned that the microfluidic device will be used in a feedback loop mechanism to assess natural variations in blood glucose levels during hemodialysis to allow the individual adjustment of glucose. Reliable and accurate detection of blood glucose is accomplished by simultaneously performing (a) blood glucose measurements, (b) autocalibration routines, (c) mediator-interferences detection, and (d) background subtractions. The electrochemical detection of blood glucose variations in the absence of electrode fouling events is performed by integrating crystalline surface layer proteins (S-layer) that function as an efficient antifouling coating, a highly-oriented immobilization matrix for biomolecules and an effective molecular sieve with pore sizes of 4 to 5 nm. We demonstrate that the S-layer protein SbpA (from Lysinibacillus sphaericus CCM 2177) readily forms monomolecular lattice structures at the various microchip surfaces (e.g. glass, PDMS, platinum and gold) within 60 min, eliminating unspecific adsorption events in the presence of human serum albumin, human plasma and freshly-drawn blood samples. The highly isoporous SbpA-coating allows undisturbed diffusion of the mediator between the electrode surface, thus enabling bioelectrochemical measurements of glucose concentrations between 500 μM to 50 mM (calibration slope δI/δc of 8.7 nA mM−1). Final proof-of-concept implementing the four microfluidic microreactor design is demonstrated using freshly drawn blood. Accurate and drift-free assessment of blood glucose concentrations (6. 4 mM) is accomplished over 130 min at 37 °C using immobilized enzyme glucose oxidase by calculating the difference between autocalibration (10 mM glc) and background measurements. The novel combination of biologically-derived nanostructured surfaces with microchip technology constitutes a powerful new tool for multiplexed analysis of complex samples.Keywords
This publication has 53 references indexed in Scilit:
- Infrared spectroscopic analysis of human interstitial fluid in vitro and in vivo using FT-IR spectroscopy and pulsed quantum cascade lasers (QCL): Establishing a new approach to non invasive glucose measurementSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2012
- Rapid liposome quality assessment using a lab-on-a-chipLab on a Chip, 2011
- Microfluidics for medical diagnostics and biosensorsChemical Engineering Science, 2011
- Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysisDiabetes Research and Clinical Practice, 2010
- Amperometric Glucose Sensors: Sources of Error and Potential Benefit of RedundancyJournal of Diabetes Science and Technology, 2010
- Detection of viruses with molecularly imprinted polymers integrated on a microfluidic biochip using contact-less dielectric microsensorsLab on a Chip, 2009
- Clinical determination of glucose in human serum by a tomato skin biosensorClinica Chimica Acta, 2008
- Fiber-optic flow-through sensor for online monitoring of glucoseAnalytical and Bioanalytical Chemistry, 2006
- Integration of enzyme immobilized single-walled carbon nanotubes mass into the microfluidic platform and its application for the glucose-detectionSensors and Actuators A: Physical, 2006
- An optical glucose biosensor based on glucose oxidase immobilized on a swim bladder membraneAnalytical and Bioanalytical Chemistry, 2005